Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Bamako, Mali: A Population-Based Cross-Sectional Study in September 2022.
Traoré B, Guindo MA, Konaté D, Kané F, Incandela NC, Traore A, Kanté S, Sidibé M, Keita B, Kasse F, Tangara K, Diallo D, Maiga IY, Thiam S, Cisse A, Siby KM, Dicko AR, Goita M, Kone D, Diallo M, Traore M, Coulibaly YI, Diakité M, Doumbia S, Dolo H, Balam S. Traoré B, et al. Among authors: guindo ma. Influenza Other Respir Viruses. 2024 Jul;18(7):e13343. doi: 10.1111/irv.13343. Influenza Other Respir Viruses. 2024. PMID: 39044355 Free PMC article.
Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas.
Traoré A, Guindo MA, Konaté D, Traoré B, Diakité SA, Kanté S, Dembélé A, Cissé A, Incandela NC, Kodio M, Coulibaly YI, Faye O, Kajava AV, Pratesi F, Migliorini P, Papini AM, Pacini L, Rovero P, Errante F, Diakité M, Arevalo-Herrera M, Herrera S, Corradin G, Balam S. Traoré A, et al. Among authors: guindo ma. Front Immunol. 2022 Apr 27;13:856033. doi: 10.3389/fimmu.2022.856033. eCollection 2022. Front Immunol. 2022. PMID: 35585976 Free PMC article.
A comprehensive analysis of drug resistance molecular markers and Plasmodium falciparum genetic diversity in two malaria endemic sites in Mali.
Diakité SAS, Traoré K, Sanogo I, Clark TG, Campino S, Sangaré M, Dabitao D, Dara A, Konaté DS, Doucouré F, Cissé A, Keita B, Doumbouya M, Guindo MA, Toure MB, Sogoba N, Doumbia S, Awandare GA, Diakité M. Diakité SAS, et al. Among authors: guindo ma. Malar J. 2019 Nov 12;18(1):361. doi: 10.1186/s12936-019-2986-5. Malar J. 2019. PMID: 31718631 Free PMC article.
P. falciparum malaria prevalence among blood donors in Bamako, Mali.
Kouriba B, Diarra AB, Douyon I, Diabaté DT, Kamissoko F, Guitteye H, Baby M, Guindo MA, Doumbo OK. Kouriba B, et al. Among authors: guindo ma. Transfus Clin Biol. 2017 Jun;24(2):62-67. doi: 10.1016/j.tracli.2017.03.002. Epub 2017 Apr 20. Transfus Clin Biol. 2017. PMID: 28434852
Normal Clinical Laboratory Ranges by Age and Sex, and Impact on Study Screening Outcomes in Rural Mali.
Doucoure M, Zeguime A, Niangaly A, Guindo MA, Doritchamou JYA, Assadou MH, Katile A, Kanoute MB, Perou S, Ouattara A, Sanogo S, Ouologuem B, Traore S, Dao B, Dembele D, Kone M, Kamate B, Sissoko K, Sankare S, Diarra S, Dolo A, Sissoko MS, Hume JCC, Cook D, Healy SA, Gorres JP, Traoré B, Gamiel J, Duffy PE, Sagara I. Doucoure M, et al. Among authors: guindo ma. Am J Trop Med Hyg. 2024 Mar 26;110(5):1021-1028. doi: 10.4269/ajtmh.23-0719. Print 2024 May 1. Am J Trop Med Hyg. 2024. PMID: 38531104
A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults.
Sagara I, Ellis RD, Dicko A, Niambele MB, Kamate B, Guindo O, Sissoko MS, Fay MP, Guindo MA, Kante O, Saye R, Miura K, Long C, Mullen GE, Pierce M, Martin LB, Rausch K, Dolo A, Diallo DA, Miller LH, Doumbo OK. Sagara I, et al. Among authors: guindo o, guindo ma. Vaccine. 2009 Dec 9;27(52):7292-8. doi: 10.1016/j.vaccine.2009.10.087. Epub 2009 Oct 27. Vaccine. 2009. PMID: 19874925 Free PMC article. Clinical Trial.
Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults.
Sagara I, Healy SA, Assadou MH, Gabriel EE, Kone M, Sissoko K, Tembine I, Guindo MA, Doucoure M, Niaré K, Dolo A, Rausch KM, Narum DL, Jones DL, MacDonald NJ, Zhu D, Mohan R, Muratova O, Baber I, Coulibaly MB, Fay MP, Anderson C, Wu Y, Traore SF, Doumbo OK, Duffy PE. Sagara I, et al. Among authors: guindo ma. Lancet Infect Dis. 2018 Sep;18(9):969-982. doi: 10.1016/S1473-3099(18)30344-X. Epub 2018 Jul 27. Lancet Infect Dis. 2018. PMID: 30061051 Free PMC article.
Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial.
Sissoko MS, Healy SA, Katile A, Zaidi I, Hu Z, Kamate B, Samake Y, Sissoko K, Mwakingwe-Omari A, Lane J, Imeru A, Mohan R, Thera I, Guindo CO, Dolo A, Niare K, Koïta F, Niangaly A, Rausch KM, Zeguime A, Guindo MA, Bah A, Abebe Y, James ER, Manoj A, Murshedkar T, Kc N, Sim BKL, Billingsley PF, Richie TL, Hoffman SL, Doumbo O, Duffy PE. Sissoko MS, et al. Among authors: guindo ma. Lancet Infect Dis. 2022 Mar;22(3):377-389. doi: 10.1016/S1473-3099(21)00332-7. Epub 2021 Nov 18. Lancet Infect Dis. 2022. PMID: 34801112 Free PMC article. Clinical Trial.
18 results